Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial.

导出 LinkOut

翻译打印收藏纠错

作者： Nuria,Muñoz-Rivas ; Jesús,Aibar ; Cristina,Gabara-Xancó ; Ángela,Trueba-Vicente ; Ana,Urbelz-Pérez ; Vicente,Gómez-Del Olmo ; Pablo,Demelo-Rodríguez ; Alberto,Rivera-Gallego ; Pau,Bosch-Nicolau ; Montserrat,Perez-Pinar ; Mónica,Rios-Prego ; Olga,Madridano-Cobo ; Laura,Ramos-Alonso ; Jesús,Alonso-Carrillo ; Iria,Francisco-Albelsa ; Edelmira,Martí-Saez ; Ana,Maestre-Peiró ; Manuel,Méndez-Bailón ; José Ángel,Hernández-Rivas ; Juan,Torres-Macho ; PROTHROMCOVID Trial Investigators

关键词 COVID-19 low-molecular-weight heparin pulmonary embolism respiratory insufficiency thrombosis

DOI 10.3390/jcm11195632

PMID 36233500

发布时间 2024-09-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Journal of clinical medicine

2022年11卷19期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

检索历史清除